Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10943)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wong CR, Nguyen MH, Lim JK. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(37): 8294-8303 [PMID: 27729736 DOI: 10.3748/wjg.v22.i37.8294] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i37/8294.htm |
| Number | Citing Articles |
| 1 |
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. Cancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
|
| 2 |
C. R. Wong, B. Njei, M. H. Nguyen, A. Nguyen, J. K. Lim. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2017; 46(11-12): 1061 doi: 10.1111/apt.14342
|
| 3 |
Donghee Kim, Osama Siddique, Brandon J. Perumpail, Aijaz Ahmed. Clinical Epidemiology of Chronic Liver Diseases. 2019; : 211 doi: 10.1007/978-3-319-94355-8_14
|
| 4 |
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
|
| 5 |
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
|
| 6 |
Veeravich Jaruvongvanich, Karn Wijarnpreecha, Patompong Ungprasert. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study. Clinics and Research in Hepatology and Gastroenterology 2017; 41(6): 629 doi: 10.1016/j.clinre.2017.03.010
|
| 7 |
Antonella Cammarota, Antonio D’Alessio, Tiziana Pressiani, Lorenza Rimassa, Nicola Personeni. Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma. Drugs & Aging 2021; 38(7): 579 doi: 10.1007/s40266-021-00871-5
|
| 8 |
Zobair M. Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhra, Puneet Puri, Mary Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry. Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices. Alimentary Pharmacology & Therapeutics 2020; 52(3): 513 doi: 10.1111/apt.15830
|
| 9 |
Shang-Shyue Tsai, Chun-Ta Hsu, ChunYuh Yang. Risk of death from liver cancer in relation to long-term exposure to fine particulate air pollution in Taiwan. Journal of Toxicology and Environmental Health, Part A 2023; 86(5): 135 doi: 10.1080/15287394.2023.2168225
|
| 10 |
Osmanuddin Ahmed, Lisa Liu, Antony Gayed, Amanjit Baadh, Mikin Patel, Jordan Tasse, Ulku Turba, Bulent Arslan. The Changing Face of Hepatocellular Carcinoma: Forecasting Prevalence of Nonalcoholic Steatohepatitis and Hepatitis C Cirrhosis. Journal of Clinical and Experimental Hepatology 2019; 9(1): 50 doi: 10.1016/j.jceh.2018.02.006
|
| 11 |
Eunüs S. Ali, Grigori Y. Rychkov, Greg J. Barritt. Store-Operated Ca²⁺ Entry (SOCE) Pathways. Advances in Experimental Medicine and Biology 2017; 993: 595 doi: 10.1007/978-3-319-57732-6_30
|
| 12 |
Wen-Yong Wu, Si-Qi Tao, Xiao-Nan Wang, Peter E Lobie, Zheng-Sheng Wu. XIAP 3′-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma. Tumor Biology 2017; 39(7): 101042831771957 doi: 10.1177/1010428317719578
|
| 13 |
P. Wainwright, E. Scorletti, C. D. Byrne. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. Current Diabetes Reports 2017; 17(4) doi: 10.1007/s11892-017-0851-x
|
| 14 |
Bin Zhang, Chenyang Zhang, Xuelian Zhang, Nannan Li, Zhengqi Dong, Guibo Sun, Xiaobo Sun. Atorvastatin promotes AMPK signaling to protect against high fat diet‑induced non‑alcoholic fatty liver in golden hamsters. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8465
|
| 15 |
Mélanie Simoes Eugénio, Muhammad Farooq, Sarah Dion, Christelle Devisme, Céline Raguenes-Nicol, Claire Piquet-Pellorce, Michel Samson, Marie-Thérèse Dimanche-Boitrel, Jacques Le Seyec. Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. Cancers 2020; 12(6): 1491 doi: 10.3390/cancers12061491
|
| 16 |
Darren Jun Hao Tan, Cheng Han Ng, Snow Yunni Lin, Xin Hui Pan, Phoebe Tay, Wen Hui Lim, Margaret Teng, Nicholas Syn, Grace Lim, Jie Ning Yong, Jingxuan Quek, Jieling Xiao, Yock Young Dan, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark D Muthiah, Rohit Loomba, Daniel Q Huang. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. The Lancet Oncology 2022; 23(4): 521 doi: 10.1016/S1470-2045(22)00078-X
|
| 17 |
Miao Fang, Min Yao, Jie Yang, Wen-Jie Zheng, Li Wang, Deng-Fu Yao. Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis. World Journal of Gastrointestinal Oncology 2020; 12(1): 66-76 doi: 10.4251/wjgo.v12.i1.66
|
| 18 |
Erin M. Sadler, Neil Mehta, Mamatha Bhat, Anand Ghanekar, Paul D. Greig, David R. Grant, Francis Yao, Gonzalo Sapisochin. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma. Transplantation 2018; 102(4): 640 doi: 10.1097/TP.0000000000002043
|
| 19 |
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(3): 363 doi: 10.3350/cmh.2021.0178
|
| 20 |
Changes in body composition and low blood urea nitrogen level related to an increase in the prevalence of fatty liver over 20 years: A cross‐sectional study. Hepatology Research 2021; 51(5): 570 doi: 10.1111/hepr.13631
|
| 21 |
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Journal of the Chinese Medical Association 2021; 84(6): 606 doi: 10.1097/JCMA.0000000000000530
|
| 22 |
Arjun Gupta, Avash Das, Kaustav Majumder, Nivedita Arora, Helen G. Mayo, Preet P. Singh, Muhammad S. Beg, Siddharth Singh. Obesity is Independently Associated With Increased Risk of Hepatocellular Cancer–related Mortality. American Journal of Clinical Oncology 2018; 41(9): 874 doi: 10.1097/COC.0000000000000388
|
| 23 |
Rina So, Jie Chen, Amar J. Mehta, Shuo Liu, Maciej Strak, Kathrin Wolf, Ulla A. Hvidtfeldt, Sophia Rodopoulou, Massimo Stafoggia, Jochem O. Klompmaker, Evangelia Samoli, Ole Raaschou‐Nielsen, Richard Atkinson, Mariska Bauwelinck, Tom Bellander, Marie‐Christine Boutron‐Ruault, Jørgen Brandt, Bert Brunekreef, Giulia Cesaroni, Hans Concin, Francesco Forastiere, Carla H. van Gils, John Gulliver, Ole Hertel, Barbara Hoffmann, Kees de Hoogh, Nicole Janssen, Youn‐hee Lim, Rudi Westendorp, Jeanette T. Jørgensen, Klea Katsouyanni, Matthias Ketzel, Anton Lager, Alois Lang, Petter L. Ljungman, Patrik K.E. Magnusson, Gabriele Nagel, Mette K. Simonsen, Göran Pershagen, Raphael S. Peter, Annette Peters, Matteo Renzi, Debora Rizzuto, Torben Sigsgaard, Danielle Vienneau, Gudrun Weinmayr, Gianluca Severi, Daniela Fecht, Anne Tjønneland, Karin Leander, Gerard Hoek, Zorana J. Andersen. Long‐term exposure to air pollution and liver cancer incidence in six European cohorts. International Journal of Cancer 2021; 149(11): 1887 doi: 10.1002/ijc.33743
|
| 24 |
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity. Metabolites 2021; 11(1): 54 doi: 10.3390/metabo11010054
|
| 25 |
Arnaud Tête, Isabelle Gallais, Muhammad Imran, Martine Chevanne, Marie Liamin, Lydie Sparfel, Simon Bucher, Agnès Burel, Normand Podechard, Brice M.R. Appenzeller, Bernard Fromenty, Nathalie Grova, Odile Sergent, Dominique Lagadic-Gossmann. Mechanisms involved in the death of steatotic WIF-B9 hepatocytes co-exposed to benzo[a]pyrene and ethanol: a possible key role for xenobiotic metabolism and nitric oxide. Free Radical Biology and Medicine 2018; 129: 323 doi: 10.1016/j.freeradbiomed.2018.09.042
|
| 26 |
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Tobias Suske, Olaf Merkel, Lukas Kenner, Andreia Luís, Andrey Kozlov, Johannes Haybaeck, Mathias Müller, Xiaonan Han, Richard Moriggl. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine 2019; 124: 154569 doi: 10.1016/j.cyto.2018.10.010
|
| 27 |
Sirui Zhou, Weijian Zhu, Hehua Guo, Yalan Nie, Jiazheng Sun, Ping Liu, Yulan Zeng. Microbes for lung cancer detection: feasibility and limitations. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1361879
|
| 28 |
Dan L. Longo, Anna M. Diehl, Christopher Day. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. New England Journal of Medicine 2017; 377(21): 2063 doi: 10.1056/NEJMra1503519
|
| 29 |
Marie Pedersen, Zorana J. Andersen, Massimo Stafoggia, Gudrun Weinmayr, Claudia Galassi, Mette Sørensen, Kirsten T. Eriksen, Anne Tjønneland, Steffen Loft, Andrea Jaensch, Gabriele Nagel, Hans Concin, Ming-Yi Tsai, Sara Grioni, Alessandro Marcon, Vittorio Krogh, Fulvio Ricceri, Carlotta Sacerdote, Andrea Ranzi, Ranjeet Sokhi, Roel Vermeulen, Kees de Hoogh, Meng Wang, Rob Beelen, Paolo Vineis, Bert Brunekreef, Gerard Hoek, Ole Raaschou-Nielsen. Ambient air pollution and primary liver cancer incidence in four European cohorts within the ESCAPE project. Environmental Research 2017; 154: 226 doi: 10.1016/j.envres.2017.01.006
|
| 30 |
Laura Iogna Prat, Emmanuel A. Tsochatzis. The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD). Hormones 2018; 17(2): 219 doi: 10.1007/s42000-018-0021-9
|
| 31 |
B. Huang, J. Bao, Y.-R. Cao, H.-F. Gao, Y. Jin. Cytochrome P450 1A1 (CYP1A1) Catalyzes Lipid Peroxidation of Oleic Acid-Induced HepG2 Cells. Biochemistry (Moscow) 2018; 83(5): 595 doi: 10.1134/S0006297918050127
|
| 32 |
Margarita N. German, Megan K. Lutz, Perry J. Pickhardt, Richard J. Bruce, Adnan Said. Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2020; 54(8): 733 doi: 10.1097/MCG.0000000000001260
|
| 33 |
V. V. Pavan Kedar Mukthinuthalapati, Vikash Sewram, Ntokozo Ndlovu, Stephen Kimani, Ashraf Omar Abdelaziz, Elizabeth Yu Chiao, Ghassan K. Abou-Alfa. Hepatocellular Carcinoma in Sub-Saharan Africa. JCO Global Oncology 2021; (7): 756 doi: 10.1200/GO.20.00425
|
| 34 |
Boushra Bathish, Holly Robertson, John F. Dillon, Albena T. Dinkova-Kostova, John D. Hayes. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Free Radical Biology and Medicine 2022; 188: 221 doi: 10.1016/j.freeradbiomed.2022.06.226
|
| 35 |
Xiaoyu Liu, Wenhui Ju, Chuanhong Huo, Shuhong Zhang, Xingang Wang, Kai Huang. Overweight and Obesity as Independent Factors for Increased Risk of Hepatocellular Cancer-Related Mortality: A Meta-Analysis. Journal of the American College of Nutrition 2021; 40(3): 287 doi: 10.1080/07315724.2020.1751007
|
| 36 |
Kathryn E. Royse, Hashem B. El-Serag, Liang Chen, Donna L. White, Lauren Hale, Haleh Sangi-Haghpeykar, Li Jiao. Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study. Journal of Women's Health 2017; 26(12): 1270 doi: 10.1089/jwh.2017.6412
|
| 37 |
Cristiana Porcu, Laura Antonucci, Barbara Barbaro, Barbara Illi, Sergio Nasi, Maurizio Martini, Anna Licata, Luca Miele, Antonio Grieco, Clara Balsano. Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. Oncotarget 2018; 9(10): 9325 doi: 10.18632/oncotarget.24282
|
| 38 |
Roberto Rodriguez-Echevarria, Jose Macias-Barragan, Marcela Parra-Vargas, Judith Rebeca Davila-Rodriguez, Eduardo Amezcua-Galvez, Juan Armendariz-Borunda. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice. World Journal of Gastroenterology 2018; 24(4): 461-474 doi: 10.3748/wjg.v24.i4.461
|
| 39 |
Mamatha Bhat, Elisa Pasini, Chiara Pastrello, Marc Angeli, Cristina Baciu, Mark Abovsky, Angella Coffee, Oyedele Adeyi, Max Kotlyar, Igor Jurisica. Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.777834
|
| 40 |
Zobair M. Younossi, Linda Henry. Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis. Endocrine Practice 2022; 28(2): 204 doi: 10.1016/j.eprac.2021.12.010
|
| 41 |
Jing Liang, Jianhui Zhu, Mengmeng Wang, Amit G. Singal, Mobolaji Odewole, Sofia Kagan, Veronica Renteria, Suyu Liu, Neehar D. Parikh, David M. Lubman. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48043-1
|
| 42 |
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
|
| 43 |
Lourianne Nascimento CAVALCANTE, Maria Gabriela Fernandes DEZAN, Cláudio Luiz da S L PAZ, André Castro LYRA. RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Arquivos de Gastroenterologia 2022; doi: 10.1590/s0004-2803.202204000-93
|
| 44 |
Yi Shen, Harvey Risch, Lingeng Lu, Xiaomei Ma, Melinda L. Irwin, Joseph K. Lim, Tamar Taddei, Karen Pawlish, Antoinette Stroup, Robert Brown, Zhanwei Wang, Wei Jia, Linda Wong, Susan T. Mayne, Herbert Yu. Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study. Cancer Causes & Control 2020; 31(4): 321 doi: 10.1007/s10552-020-01277-1
|
| 45 |
EmadA Awad, TarekM Youssef, MohamedO Aly, AzzaA R. Saab. Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patients. The Egyptian Journal of Laboratory Medicine 2020; 32(3): 76 doi: 10.4103/ejolm.ejolm_10_21
|
| 46 |
Changting Meng, Chunmei Bai, Thomas D. Brown, Leroy E. Hood, Qiang Tian. Human Gut Microbiota and Gastrointestinal Cancer. Genomics, Proteomics & Bioinformatics 2018; 16(1): 33 doi: 10.1016/j.gpb.2017.06.002
|
| 47 |
Huajun Wu, Zhiwei Zhong, Anji Wang, Chunhui Yuan, Ke Ning, Huanhuan Hu, Chao Wang, Xiangbao Yin. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01354-0
|
| 48 |
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Nicole Golob-Schwarzl, Katrin Friedbichler, Lukas Kenner, Johannes Haybaeck, Richard Moriggl. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. Cytokine 2019; 124: 154573 doi: 10.1016/j.cyto.2018.10.014
|
| 49 |
David Bernstein, Alexander J. Kovalic. Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]. Metabolism Open 2022; 13: 100158 doi: 10.1016/j.metop.2021.100158
|
| 50 |
Marco Rossato, Angelo Di Vincenzo, Claudio Pagano, Hamza El Hadi, Roberto Vettor. The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. Cells 2020; 9(4): 1047 doi: 10.3390/cells9041047
|
| 51 |
Seung-Cheol Lee, Seung-Cheol Jee, Min Kim, Soee Kim, Min Kyoung Shin, Yunkyung Kim, Jung-Suk Sung. Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells. Antioxidants 2021; 10(8): 1314 doi: 10.3390/antiox10081314
|
| 52 |
|
| 53 |
Chinasa Valerie Olovo, Xinxiang Huang, Xueming Zheng, Min Xu. Faecal microbial biomarkers in early diagnosis of colorectal cancer. Journal of Cellular and Molecular Medicine 2021; 25(23): 10783 doi: 10.1111/jcmm.17010
|
| 54 |
Valeria Abbate, Margherita Marcantoni, Felice Giuliante, Fabio Vecchio, Ilaria Gatto, Caterina Mele, Antonio Saviano, Damiano Arciuolo, Eleonora Gaetani, Maria Ferrari, Igor Giarretta, Francesco Ardito, Laura Riccardi, Alberto Nicoletti, Francesca Ponziani, Antonio Gasbarrini, Maurizio Pompili, Roberto Pola. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection. International Journal of Molecular Sciences 2017; 18(5): 1043 doi: 10.3390/ijms18051043
|
| 55 |
Yonah B. Esterson, Gregory M. Grimaldi. Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 93 doi: 10.1016/j.cld.2017.08.005
|
| 56 |
Stavros Kalpadakis, Dimitra Sifaki-Pistolla, Emmanouil K. Symvoulakis, Panagiotis Kelefiotis-Stratidakis, Lambros Vamvakas, Dimitrios Mavroudis, Christos Lionis. Reporting Liver Cancer Trends in the Island of Crete, Greece: Results from a Geo-Epidemiological Study. International Journal of Environmental Research and Public Health 2022; 19(16): 10166 doi: 10.3390/ijerph191610166
|
| 57 |
Jose Tadeu Stefano, Fernanda de Mello Malta, Priscila Brizola de Campos, Pedro Fernandes Andrade, Denise Cerqueira Paranaguá-Vezzozo, Flair Jose Carrilho, Claudia P. Oliveira. NAFLD and NASH. 2020; : 191 doi: 10.1007/978-3-030-37173-9_11
|
| 58 |
Simon Bucher, Arnaud Tête, Normand Podechard, Marie Liamin, Dounia Le Guillou, Martine Chevanne, Cédric Coulouarn, Muhammad Imran, Isabelle Gallais, Morgane Fernier, Quentin Hamdaoui, Marie-Anne Robin, Odile Sergent, Bernard Fromenty, Dominique Lagadic-Gossmann. Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24403-1
|
| 59 |
Masamichi Hayashi, Suguru Yamada, Hiroshi Tanabe, Hideki Takami, Yoshikuni Inokawa, Fuminori Sonohara, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences. Nutrition and Cancer 2021; 73(6): 996 doi: 10.1080/01635581.2020.1779758
|
| 60 |
Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash. Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis. Journal of Hepatocellular Carcinoma 2021; : 1579 doi: 10.2147/JHC.S327339
|
| 61 |
Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez, Haiping Hao. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation. Drug Metabolism and Disposition 2018; 46(9): 1310 doi: 10.1124/dmd.118.082008
|
| 62 |
Divya Saro Varghese, Bassam R. Ali. Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.674103
|
| 63 |
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen, Adriaan G. Holleboom. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers 2023; 15(4): 1308 doi: 10.3390/cancers15041308
|
| 64 |
Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt, Helmut K. Seitz. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. Journal of Clinical Medicine 2022; 11(9): 2623 doi: 10.3390/jcm11092623
|
| 65 |
Brandon J Perumpail, Muhammad Ali Khan, Eric R Yoo, George Cholankeril, Donghee Kim, Aijaz Ahmed. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(47): 8263-8276 doi: 10.3748/wjg.v23.i47.8263
|
| 66 |
Daniel Schuette, Lauren M. Moore, Marie E. Robert, Tamar H. Taddei, Barbara E. Ehrlich. Hepatocellular Carcinoma Outcome Is Predicted by Expression of Neuronal Calcium Sensor 1. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(9): 1091 doi: 10.1158/1055-9965.EPI-18-0167
|
| 67 |
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm. 2018; doi: 10.5772/intechopen.77400
|
| 68 |
Mie Mochizuki, Yasuhiro Nakayama, Kazumasa Sato, Takeshi Inukai. Focal nodular hyperplasia‐like lesion in a girl with obesity and fatty liver. Pediatrics International 2022; 64(1) doi: 10.1111/ped.15392
|
| 69 |
Rohit Loomba, Joseph K. Lim, Heather Patton, Hashem B. El-Serag. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 2020; 158(6): 1822 doi: 10.1053/j.gastro.2019.12.053
|
| 70 |
Sathish Venugopal, Ravneet k Dhanoa, Tharun Yadhav Selvamani, Shoukrie I Shoukrie, Anam Zahra, Jyothirmai Malla, Ramaneshwar Selvaraj, Ranim K Hamouda, Lubna Mohammed. Does Type 2 Diabetes Increase the Risk of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Patients: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.36079
|